Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

LUAD across diverse ethnicities

Jurisdiction:

Taiwan, United States

Organ System:

Lung

Funding Organization:

  • National Cancer Institute, USA

Research Organizations:

  • Broad Institute of MIT and Harvard, USA
  • Academia Sinica, Taiwan
  • University of Michigan, USA

Principal Investigators:

  • Michael A Gillette
  • Yu-Ju Chen
  • Marcin Cieslik
  • D.R. Mani
  • Steven A. Carr
  • Alexey I. Nesvizhskii
  • Hsuan-Yu Chen
  • Sung-Liang Yu
  • Pan-Chyr Yang
  • Gee-Chen Chang

Publication:

External Links:

Lung adenocarcinomas (LUAD) are a pressing global health problem with enduring lethality and rapidly shifting epidemiology. Proteogenomic studies integrating proteomics and post-translational modifications with genomics can identify clinical strata and oncogenic mechanisms, but have been underpowered to examine effects of ethnicity, smoking and environmental exposures, or sex on this heterogeneous disease. This comprehensive proteogenomic analysis of LUAD tumors and matched normal adjacent tissues from 406 patients across diverse geographic and demographic backgrounds explores the impact of understudied driver mutations, prognostic role of chromosomal instability, patterns of immune signaling, differential and sex-specific effects of endogenous mutagens and environmental carcinogens, and pathobiology of early-stage tumors with “late-like” characteristics. Candidate protein biomarkers are proposed for unstable tumors with highly fragmented genomes and for carcinogen exposures, and a LUAD subtype-specific atlas of therapeutic vulnerabilities is presented. These observations and the associated data resource advance the objective of precision management strategies for this devastating disease.

x